Get our free email newsletter with just one click

Sarah Connolly forced to withdraw from ENO production after cancer diagnosis

Sarah Connolly. Photo: Tristram Kenton Sarah Connolly. Photo: Tristram Kenton
by -

Sarah Connolly has been forced to pull out of forthcoming performances at English National Opera and the BBC Proms after being diagnosed with breast cancer.

The mezzo-soprano, who was awarded a damehood in 2017, said imminent surgery meant she had to withdraw from these scheduled live appearances, but that she hopes to continue with later performances and recording commitments.

She was due to star in ENO’s Orpheus and Eurydice, which will be choreographer Wayne McGregor‘s opera directing debut.

Connolly said: “Last month, I had an unwelcome birthday present – breast cancer. Like so many women afflicted with this disease, I will face whatever is coming as best I can. Imminent surgery means I must withdraw from ENO’s Orpheus and Eurydice and L’Enfance du Christ at the BBC Proms.

“I hope, however, to fulfil all my other concert and recording commitments over the coming months. I’d like to thank ENO and the BBC Proms for their kindness and understanding, and I look forward to working with them both in the near future.”

She will be replaced as Orpheus by Alice Coote, with Julie Boulianne now performing in her place at the BBC Prom.

English National Opera announces programme of new work dominated by female directors

We need your help…

When you subscribe to The Stage, you’re investing in our journalism. And our journalism is invested in supporting theatre and the performing arts.

The Stage is a family business, operated by the same family since we were founded in 1880. We do not receive government funding. We are not owned by a large corporation. Our editorial is not dictated by ticket sales.

We are fully independent, but this means we rely on revenue from readers to survive.

Help us continue to report on great work across the UK, champion new talent and keep up our investigative journalism that holds the powerful to account. Your subscription helps ensure our journalism can continue.